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Abstract
Darier (Darier-White) disease (DD) is an autosomal dominant skin disorder caused by
pathogenic mutations in the ATP2A2 gene which encodes a calcium ATPase in the
sarco-endoplasmic reticulum (SERCA2). Defects in the SERCA2 protein lead to an
impairment of cellular calcium homeostasis, which in turn, triggers cell death pathways. There is a high prevalence of neuropsychiatric disorders in patients affected
by this condition, namely intellectual disability, bipolar disorder, schizophrenia, and
suicidality. Though these associations have been well-documented over the years,
little has been discussed or investigated regarding the pathophysiological mechanisms. The goal of this article is to review the literature related to the most commonly associated neuropsychiatric disorders found in patients with DD, highlight the
pathophysiological mechanisms underlying each condition, and examine potential interventions that may be of interest for future development. A literature search was
performed using PubMed to access and review relevant articles published in the last
40 years. Keywords searched included Darier disease neuropsychiatric, Darier disease
pathophysiology, SERCA2 central nervous system, SERCA 2 skin, ATP2A2 central
nervous system, ATP2A2 skin, sphingosine-1-phosphate signalling skin, sphingosine-
1-phosphate signalling central nervous system, P2X7 receptor skin, and P2X7 receptor central nervous system. Our search resulted in 2692 articles, of which 61 articles
were ultimately included in this review.
KEYWORDS

calcium signalling, Darier disease, neuropsychiatric disorders, SERCA2

1

I NTRO D U C TI O N A N D BAC KG RO U N D

|

calcium ATPase isoform 2 also known as SERCA2.1,2 The SERCAs are
P-t ype ion motive ATPases that transport two Ca2+ ions from the cy-

Darier (Darier-White) disease (DD) is an autosomal dominant disor-

toplasm of cells to the ER lumen per one ATP molecule hydrolyzed.3

der characterized by malodorous hyperkeratotic papules in a seb-

The protein is a single polypeptide chain, 110 kDa in size, and resides

orrheic distribution, longitudinal erythronychia, v-
shaped nicking

on the ER membrane.4,5 It has ten transmembrane domains, short

of the nails, and palmoplantar pitting. The onset of the disease is

luminal loops, and three cytosolic domains. The transmembrane do-

typically at 10–20 years of age. DD is associated with mutations in

mains are critical to the function of the protein. The SERCA pump

the ATP2A2 gene which codes for a sarco-endoplasmic reticulum

is encoded by a family of three genes that are highly conserved but

This manuscript has no prior presentation.

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
1302

|

	
wileyonlinelibrary.com/journal/exd

Experimental Dermatology. 2022;31:1302–1310.

16000625, 2022, 9, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/exd.14642 by Jessica Berry - Kansas City University , Wiley Online Library on [31/10/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

Received: 25 April 2022

1303

localized on different chromosomes. The protein products of these

an intracellular signal to control a diverse array of critical brain

three genes are the three SERCA isoforms, that is, SERCA1, SERCA2,

functions including the release of neurotransmitters, regulation

and SERCA3. Although the basic function of all three SERCA isoforms

of gene expression, memory formation, and overall cell survival.17

into the ER lumen, thereby reducing

Given the critical importance of Ca2+ in neuronal function, its regu-

its intracellular levels and replenishing the ER stores, the three sub-

lation is under very strict control. Cells have evolved a complex

types have different tissue distribution and unique mechanisms of

toolkit of proteins including ion channels, exchangers, and pumps

regulation depending on the needs of the specific cell types in which

located on the plasma membrane or membrane of intracellular

they are located. Alternative splicing of the gene encoding SERCA2

organelles which work in concert to effectively regulate intracel-

produces three splice variants, SERCA2a, 2b, and 2c which differ in

lular Ca2+. These effectors along with Ca2+ binding proteins, G

their C termini and tissue localization.6,7

protein-coupled receptors, and transcriptional networks regulate

is to sequester cytosolic Ca

2+

A landmark study published by Sakuntabhai et al. 2 showed for the

Ca2+-dependent processes in the brain. There exists a 10 000-fold

first time that the mutations associated with DD are specifically local-

gradient of Ca2+ across the neuronal plasma membrane with the

ized to the ATP2A2 gene and were mapped to chromosome 12q23-

cytosolic levels being nanomolar in concentration in contrast to

q24.1. This study also unravelled the unique role of the SERCA2

millimolar levels present in the extracellular environment. The two

pump in cell-
to-
cell adhesion and abnormal keratinization, the

Ca2+ transporters located in the neuronal plasma membrane, that

major histological features of DD. Since then, a few hundred unique

is, the Na+ Ca2+ exchanger (NCX) and the plasma membrane Ca2+-

ATP2A2 mutations in SERCA2 have been found to be associated with

ATPase (PMCA) transport Ca2+ from the cytosol to the extracel-

DD.8,9 Most mutations described are missense, non-sense, in-frame

lular medium using an antiporter mechanism and ATP-dependent

deletions or insertions, which cause premature termination codons

active transport mechanism, respectively.18 As described above,

or aberrant splicing. These mutations vary between families and do

the Ca2+ transporter present in the ER membrane, that is, the

not show gene clustering. The consequence of these mutations is

SERCA, sequesters Ca2+ into the ER thus reducing cytosolic Ca2+

SERCA2 dysfunction and/or reduced expression, partially because

and replenishing the ER Ca2+ stores. Neuronal Ca2+ homeostasis

10

The

relies on rapid efflux from cells as well as quick redistribution of

inheritance of one defective copy of the gene is sufficient to cause

of increased proteasomal degradation of the mutant protein.

Ca2+ into sub-cellular organelles such as ER. Not surprisingly, dis-

8

the disease. Interestingly, the severity of the disease symptoms is

ruption of neuronal Ca2+ homeostasis by loss of NCX, PMCA, and

associated with the specific type of mutation, with missense muta-

SERCA activities has been associated with loss in cognitive func-

tions in the transduction domain of the protein resulting in the most

tion in the aging brain and in the development and progression

severe cases of DD. Importantly, these cases are also characterized

of neurodegenerative disorders, such as Alzheimer's disease and

by concurrent mental disorders.11 Although most mutations affect

Parkinson's disease.19–24 Additionally, loss of precise Ca2+ regula-

all three splice variants of SERCA2, some patients present with a

tion is also associated with psychiatric conditions, including bipolar

mutation in exon 21 which is specific for SERCA2b, demonstrating

disorder, schizophrenia, autism spectrum disorders, and intellec-

that loss of expression of this particular variant is sufficient to cause

tual disabilities. 25,26

12,13

DD.

Indeed, SERCA2b isoform is the major subtype expressed

in the epidermis of skin sections.11 In vivo skin sections of patients
with DD show decreased SERCA2b expression in the epidermis of
both lesional and non-lesional parts of the skin compared to controls. Notably, there was no observed change in the expression of
SERCA2a. The observation that SERCA2a cannot compensate for

2

|
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2.1 | Probable mechanisms of neuropsychiatric
disease associated with Darier disease

SERCA2b loss of expression is consistent with the fact that the latter
is the most prominent form and displays the highest affinity for Ca2+.

The notion that patients with skin conditions (e.g., psoriasis, eczema,

Importantly, SERCA2b is also widely expressed in the central nervous

and skin cancer) frequently face psychological challenges, such as

14

It is found

depression, anxiety, and overall poor quality of life, is well-known.

in the cerebellum (in Purkinje neurons, granule cells, and cerebellar

system (CNS) and is considered the housekeeping form.

This is largely attributed to the psychological stress related to the

glomeruli), thalamus, cortex, pontine nuclei, and mitral cells of the ol-

avoidance-coping mechanism, as well as perceived social stigma and

factory bulbs.15,16 Therefore, inherited defects in ATP2A2 as occurs

activity prevention. 27–29 However, in the case of patients with DD,

in DD would likely impair neuronal Ca2+ homeostasis which would

the link between the severe skin condition and psychological prob-

cause neuronal dysfunction, toxicity, and cell death.

lems is likely to be of a genotype–phenotype correlation. DD-causing
mutations in ATP2A2 have been shown to increase the susceptibil-

1.1 | Neuronal calcium signalling in brain

ity to neuropsychiatric dysfunction.30 There exists a large body of
literature documenting the high prevalence of severe neuropsychiatric disorders associated with DD. A large-scale population study

A vast constellation of literature has demonstrated the critical

in Sweden reported that patients diagnosed with DD were at 4.3

role of Ca2+signalling in the brain. Neurons use pulses of Ca2+ as

times higher risk of being diagnosed with bipolar disorder and at 2.3
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times higher risk of being diagnosed with schizophrenia compared to
the general population.

31

Prevalence rates in DD may be as high as

30% for major depression, 4% for bipolar disorder, and 3% for epi-

DD is associated with chronically depleted storage of Ca2+ in the ER.

Hailey-Hailey disease (HHD) is a pathophysiologically similar

The depleted levels of Ca2+ in the ER stores result in impaired pro-

disorder resulting from mutations in ATP2C1. This gene codes for a

cessing, folding, and trafficking of junctional proteins. This results

lepsy.

32

2.1.1 | UPR mechanisms

2+

calcium and manganese pump in the Golgi apparatus, namely Ca /

in an accumulation of unfolded proteins and produces the “UPR”,

Mn2+-ATPase 1 (SPCA1). A case–control study published by Curman

leading to the onset of apoptosis.1 A systematic analysis published

evaluated cognition in DD and HHD compared to healthy

by Wang et al.36 suggested that accumulation of the mutant SERCA2

control patients. This study found that DD patients had significant

protein may also contribute to the development of ER stress by acti-

cognitive impairment compared to healthy control patients, while no

vating pro-apoptotic branches of the UPR. Mutant SERCA2 proteins

significant difference was found in HHD. This further supports the

were found to accumulate as insoluble aggregates that were poorly

evidence of dysfunctional SERCA2 and its association with neuro-

degraded by proteasomes which elicited ER stress and triggered the

logical disorders.

UPR. In a study published by Onozuka et al.37, DD skin lesions dem-

et al.

33

Since neuronal Ca2+ homeostasis is critical to optimal neuronal

onstrated enhanced expression of ER stress markers CHOP, GRP78,

function, it is not surprising that DD is associated with psychiatric

calreticulin, and BiP. Bongiorno et al.38 evaluated the expression of

disorders. Pleiotropic expression of SERCA2b in the CNS may confer

anti-apoptotic proteins in DD lesional skin. This study found that

susceptibility to such disorders and may explain their prevalence in

there is downregulation of anti-apoptotic proteins, namely Bcl-2 and

DD. One possible explanation for the common effects of mutations

Bcl-xL. These findings were consistent with a similar study published

in the SERCA2 gene on skin and brain is that these tissues share a

by Pasmatzi et al.39 A schematic illustration of the UPR is depicted

common ectodermal origin and thus may share sensitivity towards

in Figure 1.

SERCA2 impairment.34 The most prevalent neuropsychiatric disorders associated with DD are intellectual disability, bipolar disorder,
and schizophrenia.1 In the remainder of this article, we will review
the unique implications that result from mutations in ATP2A2 and

2.1.2 | Sphingosine and ceramide
pathway mechanisms

pathophysiologic mechanisms that may link DD with the most common comorbid neuropsychiatric disorders.

A study by Celli et al.40 demonstrated that sphingosine levels in-

SERCA 2b plays a critical role in intracellular calcium signalling,

creased and sphingosine kinase decreased when SERCA2b was

protein synthesis, and post-translational modification of proteins.

inhibited. Inhibition of SERCA2 in keratinocytes may lead to de-

The deficiency of SERCA2b has significant implications on the

creased expression of sphingosine kinase 1 (SPHK1) which in turn

endoplasmic reticulum functioning and may contribute to cellular

may lead to increased levels of sphingosine.40 It is thought that the

1

apoptosis. Several proposed mechanisms of cellular death in re-

higher ratio of sphingosine and ceramide to sphingosine 1 phosphate

sponse to the loss of SERCA2b have been described. These include

(S1P) may lead to cell-cycle arrest and apoptosis.40 Figure 2 demon-

the unfolded protein response (UPR), abnormal sphingosine signal-

strates the cellular mechanism of S1P signalling.

ling, and increased P2X7 receptor (P2X7R) expression. P2X7R is

A large-s cale study published by Esaki et al.41 found this same

an ATP-gated cation channel that regulates the cellular influx of

pattern of elevated sphingosine and decreased S1P has been

Na+ and Ca2+ and K+ efflux. P2X7R activation mediates several cel-

demonstrated in the corpus callosum of patients with schizophre-

lular processes including inflammation, neuromodulation, cellular

nia. Schizophrenia patients have been shown to have diminished

Table 1 describes several proposed

white matter in the corpus callosum.42 It is theorized that elevated

mechanisms for cell death that may be a consequence of the mu-

levels of sphingosine lead to apoptosis of white matter in the cor-

tation in SERCA 2.

pus callosum and may be the linking mechanism with DD.41

proliferation, and cell death.

35

TA B L E 1 Proposed mechanisms of cellular dysfunction and cell death in Darier disease and associated neuropsychiatric disorders
Mechanism

Cellular response

Associated neuropsychological
disease

Reference

Unfolded protein response

Accumulation of unfolded proteins leads to apoptosis

None specifically stated

Bolognia et al.1

Decreased SPHK1 expression

Increased sphingosine and ceramide levels compared
to sphingosine 1 phosphate triggers apoptosis

Schizophrenia

Esaki et al.41

Increased P2X7 receptor
expression

Neuroinflammation, neurotoxicity, decreased neuronal
excitability

Major depressive disorder,
bipolar disorder, epilepsy

Sperlágh & Illes 45

Hyper-dopaminergic state

Loss of function of ATP2A2 leads to decreased Ca2+
ER uptake and slower decay of cytosolic Ca2+
following depolarization and increased dopamine
levels in the nucleus accumbens

Mood disorders, schizophrenia

Nakajima et al.48
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F I G U R E 1 Schematic illustration of the UPR resulting from SERCA2 inhibition. The inhibition of SERCA2 results in diminished levels
of Ca2+ within the endoplasmic reticulum (ER). Depleted levels of Ca2+ within the ER result in an accumulation of misfolded proteins and
produce ER stress. This produces ER stress and initiates the UPR which results in cellular apoptosis. Accumulation of mutated SERCA2
proteins may also elicit ER stress and initiate the UPR. This produces an enhanced expression of apoptotic proteins (CHOP, GRP78,
calreticulin, and BiP) and downregulation of anti-apoptotic proteins (Bcl-2 and Bcl-xL)

F I G U R E 2 Sphingosine-1-phosphate signalling pathway. Ceramide is degraded into sphingosine which then is phosphorylated by
sphingosine kinases (SphK1 and SphK2) to form S1P. S1P can be dephosphorylated to sphingosine by two specific phosphatases (SPP1-2)
and three lipid phosphatases (LPP1-3). S1P is then released from the endoplasmic reticulum whereby it then partakes in an intracellular
or extracellular signalling pathway. The extracellular pathway is marked by the transport of S1P outside the plasma membrane by ABC
transporters and spinsters homologue 2 (Spns2). S1P then couples to the S1P receptor (a G protein-coupled receptor) referred to as the
S1P receptor which then activates downstream cellular responses. Inhibition of SERCA2 leads to a decrease in S1P and an increase in
sphingosine by an unknown mechanism. The higher ratio of sphingosine and ceramide to sphingosine 1 phosphate (S1P) results in cell-cycle
arrest and apoptosis

2.1.3 | Neuroinflammation pathway mechanisms

important role in axonal elongation and neurotransmitter release.43
P2X7R is widely expressed in the brain, including within the hip-

Increased expression of the death receptor P2X7R may lead to in1

pocampus, a region crucial for memory formation and storage.

creased keratinocyte death. Interestingly, P2X7R is also expressed

This may help explain the prevalence of bipolar disorder and major

in the CNS in microglial and neuroglial cells.43 It has several func-

depression in patients affected by DD. One theory is that major

tions in the CNS including the regulation of cellular proliferation

depression and bipolar disorder are associated with excessive neu-

and differentiation and initiation of cell death. It also plays an

roinflammation.44 Increased expression of P2X7R is thought to
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create excessive neuroinflammation through increased release of

critical role of SERCA2 in Ca2+ regulation. More importantly, the

IL-1β from microglial cells which leads to an increase in cortisol lev-

mice showed enhanced dopamine signalling a common feature of

els through induction of corticotropin-releasing hormone secretion

schizophrenia and mood disorders. There was a significant increase

(Figure 3).

in extracellular dopamine levels in the nucleus accumbens of the
knockout mouse and altered behavioural responses to novel environments and impairment in fear conditioning. These findings have

2.1.4 | P2X7R mechanisms

elucidated for the first time how ATP2A2 mutations causing a dermatological disease may exert their pleiotropic effects on the brain

Another hypothesis is that overexpression of P2X7R may lead to a

and confer risk for psychoses and mental disorders.49

decrease in current amplitude and neuronal excitability within the
hippocampus.45 Furthermore, major depression and bipolar disorder
patients have been shown to have a shrunken hippocampus which

2.2 | Strategic treatment options for Darier disease

may be in part due to the altered function of P2X7R.46 Excessive
P2X7R stimulation has also been suggested to lead to neurotoxic

Understanding the pathophysiological mechanisms underlying the

effects associated with epilepsy, Huntington's disease, Parkinson's

most common neuropsychiatric disorders may allow clinicians to

disease, and Alzheimer's disease which may help explain their preva-

better customize and tailor their treatment of DD and the associ-

lence in patients with DD (Figure 4).45

ated neuropsychiatric disorders. Current treatment options for the

Additional susceptibility genes may also contribute to the neuro-

cutaneous manifestations of DD include topical retinoids, emol-

psychiatric disorders associated with DD. The gene responsible for

lients, and corticosteroids. Oral retinoids including isotretinoin,

DD has been mapped in region 12q23-q24.1. Bipolar disorder and

acitretin, etretinate, and alitretinoin may be effective in treating cu-

major depression have also been mapped to this region. This further

taneous disease, however, evidence is limited to small observational

supports the hypothesis that an inherited genetic defect within this

studies.50–52 Future studies are needed to develop novel treatments

region may yield some susceptibility to both diseases.

47

that can help with both cutaneous and neuropsychiatric components of DD.
Table 2 summarizes several novel treatment options for DD.

2.1.5 | Hyper-dopaminergic state

These include targeting sphingosine phosphate lyase (SGPL1), transient receptor potential canonical 1 (TRPC1), and cyclooxygenase-2

A recent study reported a direct relationship between loss of func-

(COX-2).40,53,54 It is important to note that these therapeutic modal-

tion of ATP2A2, a hyper-dopaminergic state, and behavioural abnor-

ities are limited to case reports and case series. Large-scale studies

malities characteristic of schizophrenia and mood disorders.

48

An

ATP2A2 heterozygous, brain-specific conditional knockout mouse

are necessary to determine their efficacy and role in the treatment
of DD.

was created. The ER membranes isolated from this mouse model

Inhibiting SGPL1 is believed to normalize keratinocyte differen-

showed decreased Ca2+ uptake activity and slower decay in cyto-

tiation and adhesion by restoring Ca2+ levels within the endoplasmic

solic Ca2+ following depolarization, both of which substantiated the

reticulum caused by loss of SERCA2.40 TRPC1 is a non-specific ion

F I G U R E 3 Proposed mechanism
of neuroinflammation induced by
upregulated P2X7R expression in
microglial cells. Upregulated P2X7R
expression on microglial cells leads to
increased release of IL-1β which acts
on the hypothalamus to stimulate the
activation of the hypothalamus-pituitary-
adrenal axis. Corticotropin-releasing
hormone (CRH) is released from the
hypothalamus which acts on the anterior
pituitary gland to stimulate the release
of adrenocorticotropic hormone (ACTH).
ACTH then signals the release of cortisol
from the adrenal glands resulting in an
inflammatory state throughout the body,
including the CNS
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F I G U R E 4 P2X7 receptor (P2X7R) mediated pathways in the CNS as it relates to neuropsychiatric disorders. The P2X7R is expressed on
nerve terminals, astrocytes, and microglia. Various disease processes are associated with an upregulation in the expression and activation
of this receptor. Within the nerve terminal, P2X7R activation leads to self-amplifying ATP release which creates further activation of P2X7R
on neighbouring cells. Glutamate is released from the nerve terminal and astrocytes which leads to excitotoxicity. In response to P2X7R
stimulation, astrocytes may contribute to a protein misfolding response by increased production of reactive oxygen species (ROS) and
neuroinflammation by increased production of IL-1β. Proinflammatory mediators are also released by microglial cells including IL-1 β, IL-6,
TNF-α , and ROS further leading to increased neuroinflammation. It is also thought that chronic neuroinflammation leads to a decrease in
brain-derived neurotrophic factor (BDNF) and may lead to decreased neuroplasticity

TA B L E 2 Targets of novel treatment options for Darier disease and their postulated mechanism of action
Target

Mechanism

Reference

SGPL1

Restore ER calcium levels

Celli et al.40

TRPC1

Reduce anti-apoptosis and hyperkeratosis

Pani et al. 53

COX-2

Reduce downregulation of SERCA-2

Kamijo et al. 54

P2X7R

Reduce neuroinflammation

Leduc-Pessah et al. 55

μ-Receptors and δ receptors

Reduce hyperproliferation, strengthen adhesion junctions,
reduce neuroinflammation

Lee and Elston56

α-Glucosidase

Restore localization of adhesion junctions and desmosomes

Savignac et al. 59

Calcium chelation

Enhanced release of calcium from ER

Kellermayer et al.61

Readthrough of premature stop codons

Restoration of functional ATP2A2 gene products

Pettit et al.60

channel that allows passage of Ca2+ through it and has been shown
to be upregulated in DD patients. Overexpression of TRPC1 has

disorders such as depression.35 P2X7 receptor expression in microglia may be enhanced by morphine which acts on μ-receptors in the

been suggested to lead to cellular proliferation and anti-apoptotic

CNS.55 Interestingly, opioid μ-receptors and δ-receptors are also

properties which may lead to the hyperkeratosis seen in DD pa-

found in the epidermis of the skin. Activation of these receptors may

Prostaglandin E2 is a product of the COX-2 enzyme and

enhance cellular proliferation and reduce cell-
to-
cell adhesion.56

has been shown to downregulate the expression of SERCA2 in ke-

There have been several cases of successful treatment of DD by

ratinocytes.54 Blockade of COX-2 may be useful in increasing the

utilizing naltrexone, an antagonist of opioids that binds and blocks

activity of SERCA2 in DD. The P2X7 receptor is another target of

opioid receptors and reduces and suppresses opioid cravings.57,58

interest and has been studied for various inflammatory and auto-

The mechanism is unknown, however blockade of μ-receptors and

immune diseases including osteoarthritis, rheumatoid arthritis,

δ-receptors with naltrexone may normalize cellular proliferation and

tients.

53

chronic obstructive pulmonary disease, inflammatory bowel dis-

improve adhesion.58 Additionally, this blockade may reduce P2X7

ease, chronic pain, neuroinflammation, various cancers, and mood

receptor expression leading to decreased inflammation. Miglustat
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is a pharmacologic chaperone molecule of interest that may re-
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store adhesion junctions and desmosomes yielding increased ke-

Austin Ambur

https://orcid.org/0000-0003-2191-7224

ratinocyte adhesion strength.59 Mechanistically, miglustat inhibits
α-glucosidase which blocks deglycosylation of ER proteins and thus
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CO N C LU S I O N S

Considerable evidence exists that connects DD with neuropsychiatric disorders. This review explores the relationship between DD and
the most commonly associated neuropsychiatric disorders and their
possible pathophysiologic linkage. Understanding the mechanism
underlying these disorders may help future clinicians to better treat
the disease processes. Future studies should assess whether early
intervention may reduce comorbid neuropsychological symptoms.
New treatment options are being studied that focus on targeting
SGLP1, TRPC1, COX-2, and the P2X7R, which may help clinicians
better tailor their treatment options in the future.
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